Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 4Neoplasms 3Small Cell Lung Carcinoma 2Recurrence 2Lymphoma 2Non-Erosive Reflux Disease 1Melanoma 1Lymphoma, Mantle-Cell 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Hematologic Neoplasms 1Gastrointestinal Hemorrhage 1Gastroesophageal Reflux 1Dyspepsia 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1COVID-19 1Barrett Esophagus 1Atrophy 1Advanced Solid Tumors 1Advanced Solid Malignancies 1Adenocarcinoma 1Acrocephalosyndactylia 1

Interventions

Gemcitabine 111Cisplatin 75Oxaliplatin 43pembrolizumab 34Fluorouracil 31Capecitabine 30durvalumab 26Leucovorin 25lenvatinib 23Magnetic Resonance Spectroscopy 14Irinotecan 13Nivolumab 12Albumin-Bound Paclitaxel 12Specimen Handling 11Radiofrequency Ablation 11Drug Therapy 11Biopsy 11tislelizumab 10pemigatinib 10apatinib 10Taxes 10Floxuridine 10130-nm albumin-bound paclitaxel 10Radiotherapy 9Bevacizumab 9Folfox protocol 8Carboplatin 8tremelimumab 7atezolizumab 7S 1 (combination) 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cholangiocarcinoma × Rabeprazole × Clear all
NCT05930119 2023-09-06

HMPL-453 Food Effect and PPI Study in Healthy Volunteer Study

Hutchmed

Phase 1 Completed
24 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡